Efficacy and Safety Study of Products Based on Tribulus Terrestris, L. in Men With Oligospermia

NCT06260007 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2025-04-06

No results posted yet for this study

Summary

Efficacy and Safety of Products Based on Tribulus terrestris, L. in Men with Oligospermia. It is expected that the benefits of investigational products outweigh the risks that will be mitigated or carefully managed by the study team.

Conditions

  • Oligospermia

Interventions

DRUG

Tribulus terrestris

Tribulus terrestris

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • Herbarium Laboratorio Botanico Ltda

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-12
Primary Completion
2026-02-28
Completion
2026-08-17

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06260007 on ClinicalTrials.gov